Opinion: STAT+: Medical devices makers are trying to take a page from Uber’s playbook
When it comes to device makers, regulators and payers should be on the lookout for Uber-like behavior — including aggressive marketing strategies.
In a recent of U.S. companies, medical device makers reported spending $31 million on average to bring a new product to market under the Food and Drug Administration’s 510(k) pathway for those similar to devices already approved.
